FOLH1 and prostate carcinoma: Prostate-specific membrane antigen (PSMA), also referred to as glutamate carboxypeptidase type II, is a transmembrane protein encoded by the gene FOLH1, first identified in prostate cancer cells in 1987 (12, 13).